Device Trial Radar · NCT07076160
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Jul 24, 2025
Primary completion
Sep 20, 2025
Study completion Sep 20, 2025
Sponsor
- Lead sponsor
- Johnson & Johnson Vision Care, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 22, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a 6-visit, single-masked, multi-site, 2×3 crossover, randomized-controlled, dispensing clinical trial to evaluate visual acuity.
Conditions
- Visual Acuity
- Presbyopia
Interventions
INFUSE® One Day MultifocalDevice
Test Lens
ACUVUE® OASYS MAX 1-Day Multifocal Contact LensDevice
Control Lens
Primary outcomes
What the sponsor says the trial is designed to measure.
- High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuity at Distance (4m)Time frame: 1-Week Follow-up
- High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuity at Intermediate (64cm)Time frame: 1-Week Follow-up
- High Luminance High Contrast (HLHC) Binocular logMAR Visual Acuity at Near (40cm)Time frame: 1-Week Follow-up
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Dr. James Weber & Associates, PA - City Square Blvd
Jacksonville, Florida
VRC
Jacksonville, Florida
Pearson Research Center, PA
Longwood, Florida
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.